<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO> WSJ881104-0160 </DOCNO><HL> Trimedyne System Approved </HL><SO> </SO><CO> TMED G.MES </CO><IN> PHA </IN><G> FDA </G><DATELINE> SANTA ANA, Calif.  </DATELINE><TEXT>   Trimedyne Inc., a medical technology company, said it received Food and Drug Administration approval to market its YAG laser and Laserprobe system for treating cardiovascular disease in the U.S.    The system is made by Messerschmitt-Bolkow-Blohm of West Germany, with which Trimedyne last month announced a manufacturing and distribution agreement. </TEXT></DOC>